<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114206">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01777867</url>
  </required_header>
  <id_info>
    <org_study_id>11-006873</org_study_id>
    <nct_id>NCT01777867</nct_id>
  </id_info>
  <brief_title>Cough Reflex Sensitivity and Bronchial Hyper-responsiveness</brief_title>
  <official_title>Pilot Studies Evaluating Cough Reflex Sensitivity and Bronchial Hyper-responsiveness: The Road to Cough and Wheeze in Patients With Gastroesophageal Reflux.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Manchester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to provide pilot data on the possible gastrointestinal predictors
      of respiratory hyper-responsiveness and how these relate to the clinical sub-types of GERD
      and visceral acid hypersensitivity.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Prevent respiratory consequences of reflux disease.</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Gastroesophageal Reflux Disease</condition>
  <condition>Chronic Cough</condition>
  <condition>Broncho-hyperreactivity</condition>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>non-erosive reflux disease with reflux</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>non-erosive reflux disease without reflux</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        This study will recruit participants into three groups ages 18-60 years: 12 reflux
        patients with non-erosive disease (NERD) with abnormal levels of acid reflux, 12 NERD
        patients with normal levels of reflux and 12 healthy volunteers.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  symptomatic reflux(ie one symptom at least one day a week, with at least 'moderate'
             severity)

          -  no evidence of esophagitis

          -  non-smokers

        Exclusion Criteria:

          -  previous gastrointestinal surgery (excluding minor surgeries, such as
             cholecystectomy, appendectomy

          -  active peptic ulcer disease

          -  Zollinger Ellison Syndrome

          -  Barrett's esophagus

          -  eosinophilic esophagitis

          -  cardiac disease

          -  diabetes or neurological deficit

          -  use of tricyclics

          -  selective serotonin reuptake inhibitors

          -  narcotics or benzodiazepines

          -  current use of medications that may affect symptoms of perception,lower esophageal
             sphincter basal pressure, acid clearance time or acid suppression

          -  antibiotics within 60 days

          -  Nursing mothers will be excluded

          -  allergies to citrus

          -  asthma

          -  chronic lung disease

          -  heart attack or stroke within the last three months

          -  hypersensitivity to methacholine products

          -  know aortic aneurysm

          -  uncontrolled hypertension (defined as systolic pressure greater than 200 or diastolic
             greater than 100)

          -  reduced pulmonary function test (forced expiratory volume in one second [FEV1] or the
             FEV1 to forced vital capacity [FEV1/FVC] ratio of less that 70% of predicted value)

          -  None of the controls will have any GERD symptoms or ever used antireflux treatment.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mayo Clinic Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kellie Ruday, BS, RRT</last_name>
      <phone>904-953-2255</phone>
    </contact>
    <investigator>
      <last_name>Lesley A Houghton, Ph. D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 23, 2013</lastchanged_date>
  <firstreceived_date>January 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Lesley A. Houghton</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cough</mesh_term>
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Bronchial Hyperreactivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
